Background

!
The endoscopic resection of subepithelial tumors remains challenging, especially when tumors arise from the muscularis propria [1] . Our group was the first to report on endoscopic full-thickness resection by means of an endoscopic suturing device [2, 3] . The aim of the current study was to further investigate the efficacy and safety of this resection method and to evaluate clinical outcome.
Patients and methods
!
Study design and patients
We conducted a retrospective study at a single center. Patients referred to our department with gastric subepithelial tumors between January 2007 and February 2014 were identified in our electronic documentation system. The files of the patients who underwent endoscopic full-thickness resection were then analyzed. Outcome measures were as follows: (1) the complete resection rate, defined as the proportion of tumors removed en bloc, with no macroscopically residual tumor and with negative margins on histologic examination; (2) adverse event rates; and (3) local or systemic tumor recurrence in patients with malignant lesions. Written and informed consent was obtained from all patients. The study was carried out in accordance with the Declaration of Helsinki.
Procedures
Endoscopic procedures were done with patients under deep sedation (propofol/midazolam). Carbon dioxide insufflation was used. Before resection, 1 to 3 full-thickness sutures were placed underneath the tumor. For the first 29 patients, the Plicator suturing device (NDO Surgical, Mansfield, Massachusetts, USA) was used. For the last 2 patients, we used a single-use device (GERDX; GSurg, Seeon, Germany) (• " Fig. 1 ). The suturing mechanism of this novel CE-marked device is identical to that of the Plicator, but the arms are closed hydraulically (not with a cable mechanism). A 5.8-mm video gastroscope was advanced through the device to enable direct endoscopic visualization during suturing; modified ePTFE Background and study aims: Endoscopic fullthickness resection of gastric subepithelial tumors with a full-thickness suturing device has been described as feasible in two small case series. The aim of this study was to evaluate the efficacy, safety, and clinical outcome of this resection technique. Patients and methods: After 31 patients underwent endoscopic full-thickness resection, the data were analyzed retrospectively. Before snare resection, 1 to 3 full-thickness sutures were placed underneath each tumor with a device originally designed for endoscopic anti-reflux therapy. Results: All tumors were resected successfully. Bleeding occurred in 12 patients (38.7 %); endoscopic hemostasis could be achieved in all cases. Perforation occurred in 3 patients (9.6 %), and all perforations could be managed endoscopically. Complete resection was histologically confirmed in 28 of 31 patients (90.3 %). Mean follow-up was 213 days (range, 1 -1737), and no tumor recurrences were observed. Conclusion: Endoscopic full-thickness resection of gastric subepithelial tumors with the suturing technique described above is feasible and effective. After the resection of gastrointestinal stromal tumors (GISTs), we did not observe any recurrences during follow-up, indicating that endoscopic full-thickness resection may be an alternative to surgical resection for selected patients.
pledgets and resorbable, pre-tied 4-mm sutures (G-Surg) were used. The tissue retractor was screwed into the gastric wall at the border of the tumor. The tissue was retracted into the arms of the device, the arms were closed, and a pledgeted suture was deployed underneath the tumor to create a serosa-to-serosa apposition (• " Fig. 1 ,• " Fig. 2 and• " Video 1). After gastrosopic evaluation of correct positioning of the sutures, a monofilament electrocautery snare was used to resect the tumor above the sutures. The resection site was then inspected to check for evidence of bleeding and perforation and for resection completeness; all patients underwent additional gastroscopy the next day.
Follow-up
Patients with benign lesions were scheduled for gastroscopy within 3 months. If there was no evidence of local recurrence or complications, no further follow-up was done. Patients with potentially malignant lesions were scheduled for gastroscopy and endoscopic ultrasonography (EUS) within 3 to 6 months and then once per year. In addition, those patients underwent physical examination and abdominal ultrasonography once per year.
Results
!
Patient and tumor characteristics
A total of 116 patients with gastric subepithelial tumors were identified during the study period. Of those, 31 patients underwent endoscopic full-thickness resection. Reasons for no endoscopic full-thickness resection treatment were the following: tumor size greater than 4 cm and/or predominantly extraluminal growth (n = 6); tumor size smaller than 1 cm (n = 47); EUS appearance consistent with lipoma (n = 13); patient medically unfit to undergo endoscopic full-thickness resection (n = 19). In all pa- tients initially scheduled for endoscopic full-thickness resection, the procedure was completed as planned. Tumors originated from the muscularis propria in 19 patients and from the submucosa in 9 patients; in the other patients, the originating layer could not definitely be determined by EUS. All tumors had a hypoechoic or a mixed hypo-and hyperechoic appearance. Details of the patient and tumor characteristics appear in• " Table 1 .
Procedural data and adverse events
The median number of sutures deployed was 2 (range, 1 -3). Resection was en bloc and macroscopically complete in all 31 patients (100 %) (• " Table 2 ). The median procedure time was 60 minutes. The longest procedure time was 229 minutes. This was because of a perforation and consecutive closure with 3 transmural sutures (Plicator). Active bleeding occurred in 12 patients (38.7 %). Hemostasis was achieved endoscopically in all patients, and no blood transfusions were required. No delayed bleeding was observed. Perforation was observed in 3 patients (9.6 %). In 2 of these patients, the second suture was not positioned properly underneath the tumor, causing perforation after resection. In the third patient, 1 suture was accidentally resected with the snare. In all cases, perforations were successfully closed immediately by applying 1 to 3 additional full-thickness sutures. Under continued antibiotic therapy, no signs of peritonitis occurred, and surgery was not necessary in any of the patients.
Histopathology
The histologic features of the resected specimens are listed in
• " Table 2 . Resection was histologically incomplete (R1) in 2 of 31 patients (6.4 %). In 1 patient, the tumor fragmented during retrieval, so the histologic resection status could not be determined (Rx). In the subgroup of patients with GIST histology (n = 18), the mean tumor size was 18.2 mm (range, 8 -35) . According to the Miettinen risk stratification [4] , 15 patients had low, very low, or no risk for disease progression, whereas 1 patient was considered to have a moderate risk.
Clinical outcome and follow-up
Further therapy of the patients with incomplete resection was as follows. One patient with a neuroendocrine tumor underwent laparoscopic wedge resection; histology of the resected specimen indeed showed residual tumor cells. Another patient, with an R1-resected GIST (13 mm, low mitotic index), refused further endoscopic or surgical therapy. A patient with an R1-resected glomangioma underwent another endoscopic resection, but histology did not show any residual tumor. Mean follow-up for all patients was 213 days (range, 1 -1737). Mean follow-up for patients with GISTs was 283 days (range, 1 -1737). No local or systemic recurrence was observed. One patient with a GIST and an intermediate risk for progression (tumor size, 22 mm; mitotic count, 7 per 50 high-power fields) received adjuvant therapy with imatinib (Gleevec; Novartis, Basel, Switzerland) according to current guidelines [5] . This patient died of imatinib-induced liver failure after 7 months. Local or systemic recurrence during follow-up, n (%) 0 (0)
Video 1
A 72-year-old patient presented with two subepithelial masses in the gastric fundus. Endoscopic ultrasound showed two suspicious tumors arising from the muscularis propria, suggestive of gastrointestinal stromal tumor (GIST). Because the patient was not willing to undergo surgery, a decision for endoscopic fullthickness resection was made. After three transmural sutures were applied underneath the tumor with the Plicator device, the tumors were resected with a snare. Resection was macroscopically and histologically complete. Histology showed a GIST with intermediate risk for progression (Miettinen classification).
Online content including video sequences viewable at: www.thieme-connect.de Discussion ! For patients who have subepithelial tumors larger than 2 cm with EUS features suggestive of GIST, resection is recommended [6] . In our cohort, 14 of 31 lesions were larger than 2 cm, so the indication for resection was clear. However, 17 of 31 had a size of 2 cm or less with EUS features suggestive of GIST. The management of such small lesions remains controversial. Given the malignant potential of GISTs, some authors recommend resection, although close observation is also possible [5, 6] . The diagnostic yield of EUS-guided biopsy for small lesions is low [7] , and it is a matter of debate whether tissue sampling should be done at all. Thus, endoscopic resection may provide an efficient tool to obtain a definite histologic diagnosis (with appropriate risk stratification in the case of GISTs) and may also be therapeutic . Moreover, compared with a conservative strategy, this approach may obviate the need for repeated follow-up endoscopic procedures. However, the endoscopic resection of subepithelial tumors is technically demanding. Several techniques have been described, including cap-assisted resection, endoscopic submucosal dissection, and submucosal tunnel resection [1, 8, 9] . Compared with these techniques, the resection method investigated in our study has several advantages. First, it is applicable to tumors up to a size of approximately 4 cm. Second, it is feasible in almost every location in the stomach. Because the suturing devices were originally designed to work in a retroflexed position, the technique is suitable for tumors in the proximal corpus, cardia, and even the fundus. Given the risk for perforation, transmural suturing followed by endoscopic full-thickness resection may be especially indicated for tumors arising from the muscularis. Moreover, for potentially malignant tumors, endoscopic full-thickness resection may be a more adequate therapy than superficial or even deep submucosal dissection. Endoscopic full-thickness resection and secondary defect closure with over-the-scope clips, conventional clips, loops, or T-tags have been reported [10 -12] . The advantage of the method proposed in our study is that gastric wall patency is secured before endoscopic full-thickness resection. This avoids potential contamination of the abdominal cavity. Moreover, unlike in the EndoResect study [10] , laparoscopic assistance was not necessary in our series. The concept of over-the-scope clip application before snare resection was recently reported by Sarker et al. [13] . A drawback of this technique is that the size of the cap limits the size of the lesion that can be resected. A novel device (FTRD [Full-Thickness Resection Device]; Ovesco Endoscopy, Tübingen, Germany) uses a modified 14-mm over-the-scope clip with a preloaded snare [14] . However, this device is approved only for colonic resection (mainly because of the outer diameter of 21 mm, which limits peroral introduction). Follow-up data from our patient cohort did not show any GIST recurrences. However, the mean follow-up was only 283 days, and all GISTs except one had a low risk for progression. Although endoscopic full-thickness resection may be not only a valuable diagnostic but also an effective therapeutic approach, we would like to stress that for GISTs larger than 2 cm, surgical resection is still the standard of care. However, there are patients who are either not willing or medically unfit to undergo surgery. The procedures in our study were done exclusively without endotracheal intubation, and the mean procedure time was comparable to that for laparoscopic resections [15] . Surgeons may raise concerns about tumor dissemination when capsule perforation occurs during endoscopic resection. Nevertheless, all tumors in our series could be resected en bloc, and tumor fragmentation during extraction in one patient occurred within the stomach, not within the abdominal cavity. However, tumors larger than 4 to 4.5 cm or lesions with a predominantly extraluminal growth pattern [8] should not be resected endoscopically because secure suturing underneath the tumor may not be possible, and the risk for perforation or incomplete resection is high. In our study, active bleeding at the resection site was observed in 38.7 % of cases. However, all bleeding could be managed endoscopically, and blood transfusions were not necessary. Perforation occurred in 3 patients. In all cases, the defect was recognized immediately and was efficiently closed with an additional 1 to 3 sutures. Therefore, the suturing device provides an efficient tool not only for endoscopic full-thickness resection but also for complication management. A major limitation of the resection technique proposed is the need for special endoscopic equipment. For the majority of patients, we used the Plicator from NDO, which is no longer commercially available. However, a new CE-marked single-use device is now available in Europe (GERDX; price for endoscopic fullthickness resection not yet defined). The device was used for the last 2 patients and seems to be as effective as the Plicator.
In conclusion, endoscopic full-thickness resection of subepithelial tumors with a "suture first, cut later" technique is feasible and effective. It provides a definitive histopathologic diagnosis and may also be a therapeutic approach for potentially malignant lesions in selected patients.
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